Skip to main content
OpenTrials

Clinical trial condition

Stage IV Renal Cell Cancer

Explore clinical trials studying Stage IV Renal Cell Cancer. Study availability and eligibility vary by location and protocol.

63 public trials 1 recruiting study
Refine in advanced search Browse all conditions

Stage IV Renal Cell Cancer trial results

Completed

Dalteparin and Sunitinib Malate as First-Line Therapy in Treating Patients With Kidney Cancer That is Metastatic or Cannot Be Removed by Surgery

NCT01061411

Conditions
Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +17 more
Locations
  • City of Hope Comprehensive Cancer Center Duarte, California, United States
  • Roswell Park Cancer Institute Buffalo, New York, United States
  • Academ Zienkenhuis Bij De University Amsterdam, Netherlands
  • VU University Medical Center Amsterdam, Netherlands
View Trial Details
Completed

Mycophenolate Mofetil and Cyclosporine in Reducing Graft-Versus-Host Disease in Patients With Hematologic Malignancies or Metastatic Kidney Cancer Undergoing Donor Stem Cell Transplant

NCT00078858

Conditions
Accelerated Phase Chronic Myelogenous Leukemia, Adenocarcinoma, Adult Acute Lymphoblastic Leukemia in Remission, +220 more
Locations
  • Stanford University Hospitals and Clinics Stanford, California, United States
  • Rocky Mountain Cancer Centers-Midtown Denver, Colorado, United States
  • Emory University/Winship Cancer Institute Atlanta, Georgia, United States
  • OHSU Knight Cancer Institute Portland, Oregon, United States
View Trial Details
Completed

Fludarabine Phosphate, Low-Dose Total Body Irradiation, and Donor Stem Cell Transplant in Treating Patients With Hematologic Malignancies or Kidney Cancer

NCT00005799

Conditions
Accelerated Phase Chronic Myelogenous Leukemia, Adenocarcinoma, Adult Acute Lymphoblastic Leukemia in Remission, +105 more
Locations
  • City of Hope Medical Center Duarte, California, United States
  • Stanford University Hospitals and Clinics Stanford, California, United States
  • University of Colorado Denver, Colorado, United States
  • Baylor University Medical Center Dallas, Texas, United States
View Trial Details
Completed

Low-Dose Total-Body Irradiation and Fludarabine Phosphate Followed By Donor Peripheral Blood Stem Cell Transplant in Treating Patients With Stage IV Kidney Cancer

NCT00005851

Conditions
Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +15 more
Locations
  • University of Arizona Health Sciences Center Tucson, Arizona, United States
  • Rocky Mountain Cancer Centers-Aurora Aurora, Colorado, United States
  • Baylor University Medical Center Dallas, Texas, United States
  • VA Puget Sound Health Care System Seattle, Washington, United States
View Trial Details

Related conditions